General Information of the Compound
Compound ID
CP0522899
Compound Name
4-(4-(4-methyl-1H-imidazol-5-yl)piperidin-1-yl)-5-phenylpyrimidine
    Show/Hide
Structure
Formula
C19H21N5
Molecular Weight
319.412
Canonical SMILES
Cc1nc[nH]c1C1CCN(CC1)c1ncncc1-c1ccccc1
    Show/Hide
InChI
InChI=1S/C19H21N5/c1-14-18(22-13-21-14)16-7-9-24(10-8-16)19-17(11-20-12-23-19)15-5-3-2-4-6-15/h2-6,11-13,16H,7-10H2,1H3,(H,21,22)
    Show/Hide
InChIKey
XANDGTCRWUAKFH-UHFFFAOYSA-N
Physicochemical Property
logP
3.55912
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
57.7
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44416155
ChEMBL ID
CHEMBL215509
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03805, Sodium/hydrogen exchanger 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000429 AP-1 Homo sapiens (Human)  1
1
IC50 = 520 nM
   TI
   LI
   LO
   TS